Healthcare

PostEra's Fertility programs acquired by EMD Serono, Inc.

BOSTON, Sept. 9, 2026, 10:00 GMT-04

PostEra-AcquiredbyEMD

Read full article →

First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA

BEIJING and BRIDGEWATER, Mass., Sept. 9, 2026, 09:00 GMT-04

Gan&Lee-Phase1-Study

Read full article →

Emboline Receives U.S. FDA 510(k) Clearance for Emboliner® Embolic Protection System

SANTA CRUZ, Calif., Sept. 9, 2026, 08:00 GMT-04

Emboline-FDA

Read full article →

Giovanni Caforio Appointed Operating Advisor to CD&R Funds

LONDON, Sept. 9, 2026, 04:00 GMT-04

CD&R-Giovanni-Caforio

Read full article →

EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial

LONDON and SAN SEBASTIÁN, Spain, Sept. 9, 2026, 04:00 GMT-04

Viralgen-EpilepsyGTx

Read full article →

SkylineDx Expands Direct U.S. Commercial and Clinical Investment to Accelerate Access to Merlin™ CP-GEP

ROTTERDAM, Netherlands and SAN DIEGO, Sept. 9, 2026, 03:00 GMT-04

SkylineDx-Expands

Read full article →

FDA Advisory Panel Backs BPC-157 for 503A Bulks List in 8-6-1 Vote, Promise Analysis Finds

SCOTTSDALE, Ariz., Sept. 8, 2026, 14:35 GMT-04

Promise

Read full article →

Report from Sectra's 2026 Annual General Meeting

LINKÖPING, Sweden, Sept. 8, 2026, 14:13 GMT-04

Sectra

Read full article →

Sarcoidosis Market Forecast: Emerging Therapies and Increasing Disease Awareness to Drive Expansion by 2036 | DelveInsight

LAS VEGAS, Sept. 8, 2026, 10:31 GMT-04

DELVEINSIGHT

Read full article →

Medical Supplies Market worth $248.03 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 8, 2026, 10:30 GMT-04

MARKETSANDMARKETS

Read full article →

Pharmaceutical CDMO Market to Reach US$ 270.3 Bn by 2031, Growing at 7.2% CAGR, New Report by Wissen Research

SHERIDAN, Wyo., Sept. 8, 2026, 10:21 GMT-04

WISSEN-CDMO-mkt

Read full article →

Laboratory Mixers Market worth $2.74 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 8, 2026, 10:15 GMT-04

MarketsandMarkets

Read full article →

Active Wound Care Market worth $4.50 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 8, 2026, 10:01 GMT-04

MarketsandMarkets

Read full article →

SciBase receives additional order from Castle Biosciences, advancing the collaboration

STOCKHOLM, Sept. 8, 2026, 09:36 GMT-04

SCIBASE-Castle-collab

Read full article →

Fortis Healthcare to Install India's First Upright Proton Therapy System, Advancing Precision Cancer Care

GURUGRAM, India, Sept. 8, 2026, 08:54 GMT-04

Leo-Cancer-Care

Read full article →

Brainomix and Endeavor BioMedicines Present Positive Results from Quantitative Image Analysis of Phase 2a Idiopathic Pulmonary Fibrosis (IPF) Trial at ERS Congress

OXFORD, England and CHICAGO, Sept. 8, 2026, 08:00 GMT-04

BRAINOMIX-Endeavor

Read full article →

Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets

LAVAL, QC, Sept. 8, 2026, 08:00 GMT-04

Bausch-Health

Read full article →

Carboxymethylcellulose Calcium Market worth $0.09 billion by 2036 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 8, 2026, 06:59 GMT-04

MARKETSANDMARKETS

Read full article →

Natural Field Expands NF TriSolve® Platform Into Sleep Wellness With Science-Driven Nutraceutical Solutions

SHANGHAI, Sept. 8, 2026, 06:53 GMT-04

NaturalField-Expands

Read full article →

PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure

IRVINE, Calif., Sept. 8, 2026, 06:01 GMT-04

PeproMene-Bio

Read full article →